Seres Therapeutics CEO Roger Pomerantz taking advantage of a pre-event photo op.
photo ©KeithSpiroPhotography
What rain? Attendees filled up the Novartis Institutes for Biomedical Research despite some shaky weather.
photo ©KeithSpiroPhotography
Guests talk biotech and make new connections.
photo ©KeithSpiroPhotography
Novartis's Martin Seidel kicks things off.
photo ©KeithSpiroPhotography
The crowd settles in as Foundation Medicine CEO Mike Pellini (left) and Third Rock Ventures partner Alexis Borisy (right) give an inside look at the origins of Foundation.
photo ©KeithSpiroPhotography
Pellini and Borisy noted that there were often heated debates early on in the boardroom about Foundation's identity, and exactly how to build the company.
photo ©KeithSpiroPhotography
Borisy, the man of many fedoras, greeting an attendee.
photo ©KeithSpiroPhotography
Jose-Carlos Gutierrez-Ramos left Pfizer to join a synthetic biology/microbiome hybrid startup called Synlogic. He explained the potential of the "living therapeutics" Synlogic is making, as well as the challenges that lie ahead.
photo ©KeithSpiroPhotography
Synlogic was spun out of the lab of MIT professor Jim Collins (left), who explained that the company has gone in a direction---rare metabolic disorders---that he didn't first envision. Gutierrez-Ramos (right) elaborated on the thinking behind that strategy.
photo ©KeithSpiroPhotography
An attendee checks in with a question for Collins and Gutierrez-Ramos.
photo ©KeithSpiroPhotography
Flagship Ventures CEO Noubar Afeyan, atypically wearing a suit, quipped: “Everybody’s been predicting the death of the IPO window for awhile, so I thought this would be the wake.”
photo ©KeithSpiroPhotography
Make sure to pay attention; we always set aside time for audience Q&A.
photo ©KeithSpiroPhotography
Some folks catch our cameraman in the act...
photo ©KeithSpiroPhotography
...and others are unaware that he's sneaking around.
photo ©KeithSpiroPhotography
Pomerantz wasn't sold on any of Seres's CEO candidates, so as its chairman, he "pulled a Dick Cheney" and hired himself.
photo ©KeithSpiroPhotography
An event tip for all of you: bring your business cards.
photo ©KeithSpiroPhotography
On Friday, I gave you all a recap of our latest biotech event, “Boston’s Life Science Disruptors.” As promised, today I’m circling back with some of the photos. As you’ll see, last week’s Boston monsoon cleared up just in time for the party.
Thanks again to our sponsors—BDO, Boston Children’s Hospital, Johnson & Johnson Innovation, New England Lab, and The Richmond Group—and to our speakers and event host Novartis. And of course a thanks to Keith Spiro of Keith Spiro Photography for all the shots you’ll see here. Catch you all in Boston again next time.
Join us on July 16 for a special two-part gathering that will take a unique and critical look at the Internet today, and where it is heading.
Sponsored · Whitepaper
CMC in Drug Development and Life Cycle Management
PRA Health SciencesSponsored · Whitepaper
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
IBM WatsonSponsored · Webinar
Phenotypic Screening & Profiling to Understand a Compound's Disease Impact
Eurofins Discovery© 2007-2021, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.